Dimensional Fund Advisors
EVGN icon

Dimensional Fund Advisors’s Evogene EVGN Stock Holding History

Dimensional Fund Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,904
Closed -$51K – 3482
2022
Q1 		$51K Hold
3,904
– – ﹤0.01% 3461
2021
Q4 		$64K Hold
3,904
– – ﹤0.01% 3468
2021
Q3 		$103K Hold
3,904
– – ﹤0.01% 3425
2021
Q2 		$134K Buy
3,904
+1,678
+75% +$65.7K ﹤0.01% 3383
2021
Q1 		$112K Buy
2,226
+877
+65% +$54.3K ﹤0.01% 3342
2020
Q4 		$63K Buy
+1,349
New +$47.6K ﹤0.01% 3310

Other funds holding EVGN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

Dimensional Fund Advisors's EVGN Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Evogene (EVGN) in Q2 2022, closing a stake of 3,904 shares — an estimated $51K sold.

Dimensional Fund Advisors first reported a position in EVGN in Q4 2020 and held it in 6 quarters. The position peaked at $134K in Q2 2021. 29 funds tracked by Wall St. Rank hold EVGN as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Evogene position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 3,904 Evogene shares in Q2 2022, an estimated $51K.
  • Dimensional Fund Advisors first reported a position in Evogene in Q4 2020 and held it in 6 quarters.
  • Dimensional Fund Advisors's Evogene position peaked at $134K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Evogene as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.